Combined Atrial Functional Mitral and Tricuspid Regurgitation in Atrial Fibrillation: Prevalence, Associated Factors, and Three-Dimensional Valve Remodeling
Journal of Clinical Medicine · 02.07.2026 · 15 (13) · 5198
DOI: 10.3390/jcm15135198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.07.2026. Verfasst von Andrei-Alexandru Nour und 12 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, University of Medicine and Pharmacy of Craiova, 2 Petru Rares St., 200349 Craiova, Romania. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Executive Unit for Financing Higher Education, Research, Development and Innovation, Romanian Ministry of Research, Innovation and Digitalization, Executive Agency for Higher Education, Research, Development and Innovation Funding.
Abstract (Originalsprache)
Background/Objectives: Atrial fibrillation (AF) may cause functional mitral regurgitation (MR) and tricuspid regurgitation (TR) through atrial remodeling and annular dilation. However, the prevalence and structural characteristics of combined MR/TR in AF are not well defined. We aimed to determine the prevalence, clinical profile, and factors associated with combined clinically significant MR and TR in AF patients.
Methods
In this prospective observational study (REMO-FIB), 175 consecutive AF patients underwent comprehensive transesophageal echocardiography with three-dimensional mitral valve analysis. After excluding organic MR and significant aortic valve disease, 125 patients were analyzed. Patients were classified into four groups according to the presence of moderate/severe MR and/or TR. Multivariable logistic regression evaluated factors associated with the combined phenotype.
Results
Among 125 patients, 53 (42.4%) had no significant MR/TR, 33 (26.4%) had isolated MR, 11 (8.8%) had isolated TR, and 28 (22.4%) had combined MR/TR. Compared with patients without regurgitation, those with combined MR/TR had higher symptom burden (EHRA class, p = 0.036), more heart failure (92.9% vs. 67.9%, p = 0.048), larger left (47.0 vs. 42.0 mm, p = 0.002) and right atria (42.0 vs. 38.0 mm, p < 0.001), higher pulmonary artery pressure (40.0 vs. 28.0 mmHg, p = 0.004), and lower left ventricular ejection fraction (47.5% vs. 55.0%, p = 0.006). Three-dimensional analysis showed larger mitral annular perimeter (129.0 vs. 121.0 mm, p = 0.009), greater annular area (12.7 vs. 11.1 cm2, p = 0.014), longer anterior leaflet length (26.5 vs. 24.0 mm, p < 0.001), and greater tenting area (2.1 vs. 1.4 cm2, p = 0.002). Factors independently associated with the combined phenotype were female sex (OR 4.60, p = 0.015), lower ejection fraction (OR 0.47 per SD, p = 0.005), and larger right atrial diameter (OR 1.85 per SD, p = 0.037). Model discrimination was good (AUC 0.81).
Conclusions
Combined moderate/severe MR and TR affects over one-fifth of AF patients without organic valve disease and is associated with advanced biatrial remodeling, adverse symptoms, and heart failure. Comprehensive assessment of both atrioventricular valves should be considered in AF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School, University of Medicine and Pharmacy of Craiova, 2 Petru Rares St., 200349 Craiova, Romania.
- Department of Cardiology, Filantropia Clinical Hospital, 28 Sararilor St., 200516 Craiova, Romania.
- Department of Cardiology, University of Medicine and Pharmacy of Craiova, 2 Petru Rares St., 200349 Craiova, Romania.
- Department of Cardiology, Clinical Emergency County Hospital of Craiova, 1 Tabaci St., 200642 Craiova, Romania.
- Department of Cardiovascular Surgery, Clinical Emergency County Hospital of Craiova, 1 Tabaci St., 200642 Craiova, Romania.
- Department of Cardiology, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Bld., 050474 Bucharest, Romania.
ORCID-Profile: Diana-Ruxandra Hădăreanu, Despina-Manuela Toader, Maria-Livia Iovănescu, Ionuț Donoiu, Cristina Florescu
Förderung
- Executive Unit for Financing Higher Education, Research, Development and Innovation
- Romanian Ministry of Research, Innovation and Digitalization
- Executive Agency for Higher Education, Research, Development and Innovation Funding
Zitieren
APA
Nour, A. A., Hădăreanu, D. R., Toader, D. M., Hădăreanu, C. D., Iovănescu, M. L., Mihu-Marinescu, A., Târtea, G. C., Donoiu, I., Mustafa, E. R., Munteanu-Mirea, O., Radu, R. I., Istrătoaie, O., & Florescu, C. (2026). Combined Atrial Functional Mitral and Tricuspid Regurgitation in Atrial Fibrillation: Prevalence, Associated Factors, and Three-Dimensional Valve Remodeling. Journal of Clinical Medicine, 15(13), 5198. https://doi.org/10.3390/jcm15135198
Vancouver
Nour AA, Hădăreanu DR, Toader DM, Hădăreanu CD, Iovănescu ML, Mihu-Marinescu A, et al. Combined Atrial Functional Mitral and Tricuspid Regurgitation in Atrial Fibrillation: Prevalence, Associated Factors, and Three-Dimensional Valve Remodeling. Journal of Clinical Medicine. 2026;15(13):5198. doi:10.3390/jcm15135198
BibTeX
@article{Nour2026,
author = {Nour, Andrei-Alexandru and Hădăreanu, Diana-Ruxandra and Toader, Despina-Manuela and Hădăreanu, Călin-Dinu and Iovănescu, Maria-Livia and Mihu-Marinescu, Anca and Târtea, Georgică-Costinel and Donoiu, Ionuț and Mustafa, Edme-Roxana and Munteanu-Mirea, Oana and Radu, Răzvan-Ilie and Istrătoaie, Octavian and Florescu, Cristina},
title = {Combined Atrial Functional Mitral and Tricuspid Regurgitation in Atrial Fibrillation: Prevalence, Associated Factors, and Three-Dimensional Valve Remodeling},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {13},
pages = {5198},
doi = {10.3390/jcm15135198}
}
EUVIMED